MarketCap
Facebook
X
TelegramQuartalsbericht 2023-Q3
hinzugefügt 08.11.2023
Invitae Corporation EV 2011-2026 | NVTA
EV Jährlich Invitae Corporation
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2.11 B | 3.39 B | 7.99 B | 2.03 B | 943 M | 403 M | 240 M | 143 M | 105 M | 47.3 M | 38.7 M | - |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 7.99 B | 38.7 M | 1.58 B |
EV anderer Aktien in der Diagnostik & Forschung
| Name | EV | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
 |
Centogene N.V.
CNTG
|
-19.1 M | - | -6.23 % | $ 30.6 M |  Germany |
 |
Aspira Women's Health
AWH
|
10.6 M | - | -6.19 % | $ 10.5 M |  USA |
 |
Agilent Technologies
A
|
45.8 B | $ 116.92 | 2.68 % | $ 35.5 B | USA |
 |
Biocept
BIOC
|
15 M | - | -13.05 % | $ 7.29 M | USA |
 |
DermTech
DMTK
|
70.4 M | - | -11.32 % | $ 2.94 M | USA |
 |
Castle Biosciences
CSTL
|
665 M | $ 25.62 | 3.18 % | $ 712 M | USA |
 |
Enzo Biochem
ENZ
|
-22.7 M | - | -8.98 % | $ 14.8 K | USA |
 |
Danaher Corporation
DHR
|
145 B | $ 195.29 | 2.24 % | $ 139 B | USA |
 |
Exact Sciences Corporation
EXAS
|
22 B | - | - | $ 19.8 B | USA |
 |
Fulgent Genetics
FLGT
|
502 M | $ 16.25 | 2.14 % | $ 491 M | USA |
 |
CareDx, Inc
CDNA
|
1.04 B | $ 18.15 | 2.72 % | $ 967 M | USA |
 |
Oxford Immunotec Global PLC
OXFD
|
26.2 M | - | - | $ 562 M |  Britain |
 |
Guardant Health
GH
|
15.2 B | $ 94.73 | 1.53 % | $ 11.9 B | USA |
 |
DexCom
DXCM
|
28.2 B | $ 65.41 | 3.64 % | $ 25.5 B | USA |
|
Akumin
AKU
|
1.64 B | - | -17.87 % | $ 25.9 M |  Canada |
 |
Heska Corporation
HSKA
|
851 M | - | - | $ 1.31 B | USA |
 |
HTG Molecular Diagnostics
HTGM
|
3.16 M | - | -20.0 % | $ 1.06 M | USA |
 |
Burning Rock Biotech Limited
BNR
|
433 M | $ 16.5 | 2.52 % | $ 178 M |  China |
 |
Co-Diagnostics
CODX
|
-1.92 M | $ 4.4 | 101.83 % | $ 5.85 M | USA |
 |
ICON Public Limited Company
ICLR
|
26.4 B | $ 108.69 | 1.43 % | $ 8.97 B |  Irlanda |
 |
Accelerate Diagnostics
AXDX
|
92.6 M | - | -61.36 % | $ 2.46 M | USA |
 |
Illumina
ILMN
|
15.3 B | $ 127.4 | 0.76 % | $ 20.3 B | USA |
 |
IQVIA Holdings
IQV
|
49.6 B | $ 174.05 | 2.06 % | $ 29.9 B | USA |
 |
Global Cord Blood Corporation
CO
|
-2.77 B | - | - | $ 399 M | China |
 |
Fluidigm Corporation
FLDM
|
6.64 M | - | 1.08 % | $ 308 M | USA |
 |
Genetic Technologies Limited
GENE
|
9.21 B | - | - | $ 7.1 B |  Australia |
 |
Genetron Holdings Limited
GTH
|
251 M | - | 0.12 % | $ 80.1 M | China |
 |
Laboratory Corporation of America Holdings
LH
|
33.1 B | $ 274.58 | 2.01 % | $ 22.8 B | USA |
 |
Lantheus Holdings
LNTH
|
5.9 B | $ 79.47 | 1.78 % | $ 5.36 B | USA |
 |
Charles River Laboratories International
CRL
|
11.4 B | $ 176.29 | 3.94 % | $ 8.74 B | USA |
 |
PRA Health Sciences, Inc.
PRAH
|
5.02 B | - | - | $ 10.7 B | USA |
 |
Motus GI Holdings
MOTS
|
568 K | - | -34.28 % | $ 263 K |  Israel |
 |
Medpace Holdings
MEDP
|
14 B | $ 522.84 | 2.82 % | $ 15.1 B | USA |
 |
Mettler-Toledo International
MTD
|
32.1 B | $ 1 318.82 | 3.84 % | $ 27.2 B |  Schweiz |
 |
Myriad Genetics
MYGN
|
598 M | $ 4.87 | 2.64 % | $ 451 M | USA |
|
Biodesix
BDSX
|
142 M | $ 14.75 | 1.48 % | $ 1.91 B | USA |
 |
NeoGenomics
NEO
|
1.85 B | $ 8.36 | 3.72 % | $ 1.07 B | USA |
 |
Neogen Corporation
NEOG
|
2.26 B | $ 10.53 | 5.51 % | $ 2.28 B | USA |
 |
OpGen
OPGN
|
10.3 M | - | -16.95 % | $ 1.54 M | USA |
 |
Natera
NTRA
|
5.53 B | $ 212.64 | 1.61 % | $ 20.9 B | USA |
 |
PerkinElmer
PKI
|
4 B | - | -0.91 % | $ 14.7 B | USA |
 |
Pacific Biosciences of California
PACB
|
1.21 B | $ 1.5 | 3.82 % | $ 450 M | USA |
 |
Quotient Limited
QTNT
|
393 M | - | -11.32 % | $ 1.1 M | Schweiz |
 |
Precipio
PRPO
|
42.5 M | $ 28.4 | -0.37 % | $ 45.6 M | USA |
 |
Personalis
PSNL
|
229 M | $ 6.5 | 5.35 % | $ 385 M | USA |
 |
QIAGEN N.V.
QGEN
|
11.3 B | - | - | $ 10.6 B |  Niderland |
 |
Anixa Biosciences
ANIX
|
990 K | $ 2.68 | -0.56 % | $ 87 K | USA |
 |
Biomerica
BMRA
|
6.63 M | $ 2.14 | -0.93 % | $ 4.92 M | USA |
 |
BioNano Genomics
BNGO
|
34.1 M | $ 1.17 | 0.17 % | $ 6.37 M | USA |
 |
Interpace Biosciences
IDXG
|
16.3 M | $ 2.0 | 0.25 % | $ 8.85 M | USA |